BioHarvest Sciences Inc. (NASDAQ:BHST) reported a 62% year-over-year increase in fourth-quarter revenue, reaching $7.3 million, as the biotechnology company saw strong demand for its VINIA product lines and expanded its contract development and manufacturing organization (CDMO) services.
Full-year revenue nearly doubled to $25.2 million, with gross margins improving by 1,000 basis points to 55%.
PVH Corp. (NYSE:PVH), the company that owns and operates the brands Tommy Hilfiger and Calvin Klein, reported better-than-expected financial results for the fourth quarter, sending its shares soaring.
Shares of PVH surged 17.3% to about $76 at midday on Tuesday.
Ideal Power Inc (NASDAQ:IPWR) announced that it has successfully completed all deliverables for its first solid-state circuit breaker (SSCB) design win, finishing three months ahead of schedule.
The company said the early completion strengthens the company’s partnership with a leading Asian circuit protection equipment manufacturer and positions its B-TRAN semiconductor power switch for broader market adoption.
Johnson & Johnson (NYSE:JNJ) shares moved almost 5% lower after a US bankruptcy judge rejected its $10 billion settlement proposal which sought to resolve tens of thousands of lawsuits alleging its talc-based products caused ovarian cancer.
Judge Christopher Lopez of the US Bankruptcy Court for the Southern District of Texas, Houston, dismissed the bankruptcy claim filed by J&J subsidiary Red River Talc, citing flaws in the voting process for personal injury claimants.
Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has completed human testing of its Health Canada-licensed barium contrast media products and is preparing for its launch in Canada.
The study involved 24 test subjects who received oral doses of Voyageur’s contrast agents, followed by diagnostic imaging.